Metrics in Balance NV Market Cap ($144.89K)
Market Cap & Net Worth: Metrics in Balance NV (MLMIB)
Metrics in Balance NV market cap. Metrics in Balance NV (PA:MLMIB) has a market capitalization of $144.89K (€123.93K) as of November 1, 2026. Listed on the PA stock exchange, this France-based company holds position #31427 globally and #592 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Metrics in Balance NV's stock price €0.03 by its total outstanding shares 4390543 (4.39 Million).
Metrics in Balance NV Market Cap History (2018–2026)
Metrics in Balance NV market cap history from 2018 to 2026. Data shows change from $35.88 Million to $169.39K (-44.95% CAGR). Check Metrics in Balance NV (MLMIB) share price today for real-time trading data and today's change.
Metrics in Balance NV Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Metrics in Balance NV's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Metrics in Balance NV to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
5133.01x
Metrics in Balance NV's market cap is 5133.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $35.88 Million | $1.35K | -$300.67K | 26597.27x | N/A |
| 2019 | $38.50 Million | $32.73K | -$107.99K | 1176.32x | N/A |
| 2020 | $17.35 Million | $41.29K | $871.87 | 420.16x | 19899.25x |
| 2021 | $8.21 Million | $55.02K | $2.59K | 149.26x | 3166.08x |
| 2022 | $1.54 Million | $300.00 | -$53.46K | 5133.01x | N/A |
Competitor Companies of MLMIB by Market Capitalization
Companies near Metrics in Balance NV in the global market cap rankings as of November 1, 2026. Also see total assets of Metrics in Balance NV for a full breakdown of the balance sheet.
Key companies related to Metrics in Balance NV by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #248 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #451 globally with a market cap of $61.32 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #626 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1151 globally with a market cap of $22.30 Billion USD ( AU$31.51 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #248 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $994.58 |
| #451 | Cencora Inc. | NYSE:COR | $61.32 Billion | $330.84 |
| #626 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $250.48 |
| #1151 | Sigma Healthcare Ltd | AU:SIG | $22.30 Billion | AU$2.73 |
Market Capitalization of Metrics in Balance NV (2018–2026)
Market capitalization of Metrics in Balance NV from 2018 to today. Between 2018 and today, Metrics in Balance NV's market cap moved from $35.88 Million to $ 169.39K, with a yearly change of -44.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €169.39K | 0.00% |
| 2025 | €169.39K | 0.00% |
| 2024 | €169.39K | -81.67% |
| 2023 | €923.94K | -40.00% |
| 2022 | €1.54 Million | -81.25% |
| 2021 | €8.21 Million | -52.66% |
| 2020 | €17.35 Million | -54.93% |
| 2019 | €38.50 Million | +7.30% |
| 2018 | €35.88 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Metrics in Balance NV was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $144.89K USD |
| MoneyControl | $144.89K USD |
| MarketWatch | $144.89K USD |
| marketcap.company | $144.89K USD |
| Reuters | $144.89K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Metrics in Balance NV
Metrics in Balance N.V. owns and operates healthcare clinics in the Netherlands. The company offers chiropractic care and physical therapy, lifestyle testing, and occluso-posture therapy services. Metrics in Balance N.V. was incorporated in 2016 and is based in Gent, Belgium.